Preclinical evaluation of ASK1 inhibitor SRT 055 as a potential development candidate for ALS

Ended Project Grant Awarded Last action

Award ID
HT94252310182
Recipient
Awarding agency
Obligated
$550,000

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Originally
Place of performance
Seattle, WA 98101, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment $0
Amendment $0
Amendment $0
Amendment $2,905
Original award $547,095

Quick answers

Who received award HT94252310182?

HT94252310182 was awarded to Seal Rock Therapeutics, Inc. by Defense Health Agency (Department of Defense) on March 1, 2023.

How much is award HT94252310182 worth?

$550,000 has been obligated on HT94252310182.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award